Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/103809
Title: Locking the 150-cavity open : in silico design and verification of influenza neuraminidase inhibitors
Authors: Han, Nanyu
Mu, Yuguang
Keywords: DRNTU::Science::Biological sciences::Microbiology
Issue Date: 2013
Source: Han, N., & Mu, Y. (2013). Locking the 150-Cavity Open: In Silico Design and Verification of Influenza Neuraminidase Inhibitors. PLoS ONE, 8(8).
Series/Report no.: PLoS ONE
Abstract: Neuraminidase (NA) of influenza is a key target for virus infection control and the recently discovered open 150-cavity in group-1 NA provides new opportunity for novel inhibitors design. In this study, we used a combination of theoretical methods including fragment docking, molecular linking and molecular dynamics simulations to design ligands that specifically target at the 150-cavity. Through in silico screening of a fragment compound library on the open 150-cavity of NA, a few best scored fragment compounds were selected to link with Zanamivir, one NA-targeting drug. The resultant new ligands may bind both the active site and the 150-cavity of NA simultaneously. Extensive molecular dynamics simulations in explicit solvent were applied to validate the binding between NA and the designed ligands. Moreover, two control systems, a positive control using Zanamivir and a negative control using a low-affinity ligand 3-(p-tolyl) allyl-Neu5Ac2en (ETT, abbreviation reported in the PDB) found in a recent experimental work, were employed to calibrate the simulation method. During the simulations, ETT was observed to detach from NA, on the contrary, both Zanamivir and our designed ligand bind NA firmly. Our study provides a prospective way to design novel inhibitors for controlling the spread of influenza virus.
URI: https://hdl.handle.net/10356/103809
http://hdl.handle.net/10220/16533
ISSN: 1932-6203
DOI: http://dx.doi.org/10.1371/journal.pone.0073344
Rights: © 2013 Han et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:SBS Journal Articles

Google ScholarTM

Check

Altmetric

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.